Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis

Publisher: John Wiley & Sons Inc

E-ISSN: 2326-5205|70|2|204-211

ISSN: 2326-5191

Source: ARTHRITIS & RHEUMATOLOGY, Vol.70, Iss.2, 2018-02, pp. : 204-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content